Your session is about to expire
← Back to Search
VR Assessment for Retinal Disease
Study Summary
This trial is testing a virtual reality tool to see if it can help assess mobility in people with retinal disease. Eligible participants are those aged 5 and older with retinal disease that affects their vision, and healthy volunteers. The VR tool will be used to navigate through 4 obstacle courses presented in VR.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I am at least five years old.I can follow the testing procedures required for this study.I am currently participating in another clinical trial.I do not have any eye diseases.
- Group 1: Participants
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA given its stamp of approval to the VR Motility Tool?
"The potential safety of the VR Motility Tool was assigned a score of 1, as it is currently being assessed in Phase 1 clinical trials without ample evidence for both its efficacy and security."
What is the current enrollment size of this experiment?
"Affirmative. The information on clinicaltrials.gov reports that this study is currently recruiting suitable participants, first posted on December 5th 2022 and most recently modified November 29th 2022. In total, 165 volunteers are needed from a single site location."
Are there presently any openings for this clinical experiment?
"Affirmative. Data published on clinicaltrials.gov corroborates that this experiment, which was first announced on December 5th 2022, is actively looking for participants. A total of 165 patients are needed from a single centre."
Share this study with friends
Copy Link
Messenger